NJ A4447

Allows practitioners with a significant beneficial interest in a pharmacy integrated with an oncology practice to refer patients to that pharmacy, provided they disclose the financial interest to patients

The integrated pharmacy must only dispense medications exclusively to patients of the oncology practice and meet specific requirements including direct access to patient records, patient communication, and consultation with treating physicians

Exempts from self-referral restrictions certain value-based arrangements under Medicare programs and alternative payment models registered with the Department of Health

Requires practitioners making permitted referrals to provide written disclosure forms to patients and post the disclosure in a conspicuous place in their office

Maintains existing exceptions for ambulatory surgery, renal dialysis, and procedures performed personally by the referring practitioner at their own medical office